Advertisement

Ads Placeholder
Loading...

Viatris Inc.

VTRSNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$13.44
$-0.19(-1.39%)
U.S. Market opens in 0h 33m

Viatris Inc. Fundamental Analysis

Viatris Inc. (VTRS) shows weak financial fundamentals with a PE ratio of -4.41, profit margin of -24.58%, and ROE of -22.99%. The company generates $14.3B in annual revenue with weak year-over-year growth of -4.46%.

Key Strengths

PEG Ratio-1.05

Areas of Concern

ROE-22.99%
Operating Margin-18.62%
We analyze VTRS's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -27.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-27.0/100

We analyze VTRS's fundamental strength across five key dimensions:

Efficiency Score

Weak

VTRS struggles to generate sufficient returns from assets.

ROA > 10%
-9.45%

Valuation Score

Excellent

VTRS trades at attractive valuation levels.

PE < 25
-4.41
PEG Ratio < 2
-1.05

Growth Score

Weak

VTRS faces weak or negative growth trends.

Revenue Growth > 5%
-4.46%
EPS Growth > 10%
-12.62%

Financial Health Score

Excellent

VTRS maintains a strong and stable balance sheet.

Debt/Equity < 1
1.00
Current Ratio > 1
1.30

Profitability Score

Weak

VTRS struggles to sustain strong margins.

ROE > 15%
-2299.21%
Net Margin ≥ 15%
-24.58%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is VTRS Expensive or Cheap?

P/E Ratio

VTRS trades at -4.41 times earnings. This suggests potential undervaluation.

-4.41

PEG Ratio

When adjusting for growth, VTRS's PEG of -1.05 indicates potential undervaluation.

-1.05

Price to Book

The market values Viatris Inc. at 1.05 times its book value. This may indicate undervaluation.

1.05

EV/EBITDA

Enterprise value stands at -5.38 times EBITDA. This is generally considered low.

-5.38

How Well Does VTRS Make Money?

Net Profit Margin

For every $100 in sales, Viatris Inc. keeps $-24.58 as profit after all expenses.

-24.58%

Operating Margin

Core operations generate -18.62 in profit for every $100 in revenue, before interest and taxes.

-18.62%

ROE

Management delivers $-22.99 in profit for every $100 of shareholder equity.

-22.99%

ROA

Viatris Inc. generates $-9.45 in profit for every $100 in assets, demonstrating efficient asset deployment.

-9.45%

Following the Money - Real Cash Generation

Operating Cash Flow

Viatris Inc. produces operating cash flow of $2.31B, showing steady but balanced cash generation.

$2.31B

Free Cash Flow

Viatris Inc. generates strong free cash flow of $1.82B, providing ample flexibility for dividends, buybacks, or growth.

$1.82B

FCF Per Share

Each share generates $1.58 in free cash annually.

$1.58

FCF Yield

VTRS converts 11.76% of its market value into free cash.

11.76%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-4.41

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-1.05

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.05

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.08

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.30

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.23

vs 25 benchmark

ROA

Return on assets percentage

-0.09

vs 25 benchmark

ROCE

Return on capital employed

-0.09

vs 25 benchmark

How VTRS Stacks Against Its Sector Peers

MetricVTRS ValueSector AveragePerformance
P/E Ratio-4.4128.45 Better (Cheaper)
ROE-22.99%763.00% Weak
Net Margin-24.58%-45265.00% (disorted) Weak
Debt/Equity1.000.34 Weak (High Leverage)
Current Ratio1.302795.60 Neutral
ROA-9.45%-16588.00% (disorted) Weak

VTRS outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Viatris Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-39.86%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-1871.56%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-40.08%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ